phthalimidine has been researched along with Leukemia, Myeloid, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, P; Tian, J; Yang, L; Yang, Y; Zhang, F; Zhang, H; Zhou, J | 1 |
2 other study(ies) available for phthalimidine and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
3-Hydroxyisoindolin-1-one derivates: Synthesis by palladium-catalyzed CH activation as BRD4 inhibitors against human acute myeloid leukemia (AML) cells.
Topics: Antineoplastic Agents; Apoptosis; Catalysis; Cell Cycle Proteins; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Leukemia, Myeloid, Acute; Molecular Docking Simulation; Molecular Structure; Palladium; Phthalimides; Structure-Activity Relationship; Transcription Factors; Tumor Cells, Cultured | 2019 |
Phthalimide-Conjugated Ligands Promote Selective Protein Destabilization.
Topics: Adaptor Proteins, Signal Transducing; Azepines; Cell Cycle Proteins; Humans; Leukemia, Myeloid, Acute; Ligands; Nuclear Proteins; Peptide Hydrolases; Phthalimides; Proteasome Endopeptidase Complex; Transcription Factors; Triazoles; Ubiquitin-Protein Ligases | 2015 |